Maurice Blake says he never knew that one-in-four black men face prostate cancer - double the average.

Scientists have reported results from an early-stage trial of an immunotherapy drug called VIR-5500. The drug offers new hope for men with advanced prostate cancer who have stopped responding to other ...

Monte Rosa Therapeutics recently reported updated Phase 1/2 data showing that its investigational GSPT1 degrader MRT-2359, in combination with enzalutamide, was well-tolerated and produced positive ...

The research lays a foundation for the possibility that aggressive prostate cancer can probably be detected through a few drops of semen or blood in the long term. Prostate cancer is the most common ...

Prostate cancer usually starts to grow on the outer part of the prostate, which means it doesn't press on the tube that ...

Oxybutynin significantly reduced hot flash frequency and severity compared with placebo among men with prostate cancer ...

Community equipment services specialists Medequip has chosen to partner with Prostate Cancer UK for 2026 after it conducted a ...

However, men with higher PSA levels did show modest improvements in survival, suggesting that hormone therapy might be worthwhile for them. PSA (prostate-specific antigen) is produced by the prostate ...

A new study has uncovered a troubling potential link between microplastics and cancerous prostate tumors. While the study doesn't prove causation, it raises questions about the effects microplastics ...

NHS Herefordshire and Worcestershire urges men to check prostate cancer risk during Awareness Month. Learn symptoms, risk factors and use ...

An experimental immunotherapy drug called VIR-5500 has driven prostate-specific antigen (PSA) levels down by as much as 99% in some men with metastatic castration-resistant prostate cancer, according ...

New formulation of its widely-used U.S. market-leading PSMA PET imaging agent combines the diagnostic performance of PYLARIFY ® (piflufolastat F 18) with the potential for larger ...